Although CHIP is defined by the absence of hematologic malignancy, such as myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), or acute myeloid leukemia (AML) (5), its association with myriad disease pathologies underscores its importance in contemporary hematology research. This evidence concerns the gene STUB1 and myelodysplastic syndrome.